Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

United States

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey

Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey

Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity), Commack, New York

Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York

Mount Sinai Hospital, New York, New York

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York

Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York